A Study to Evaluate Efficacy and Safety of SAR441566 in Adults With Plaque Psoriasis
18-75 years
All genders
Phase 2
Interventional
This is a Phase 2, international, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, 12-week study. It is designed to assess the therapeutic dose, efficacy, and safety of treatment with SAR441566 in male and female adults with moderate to severe plaque psoriasis. Study details include a screening period (4 weeks and not less …